Sign in to continue:

Wednesday, October 22nd, 2025

Morningstar’s 10 Cheapest Wide-Moat US Stocks for 2025: Estee Lauder, Pfizer, Nike Lead the Pack

Morningstar Equity Research has unveiled its 10 “cheap, wide-moat” US stocks for 2025, spotlighting companies with strong competitive advantages that enable them to fend off rivals and deliver long-term value to investors.

What Are Wide-Moat Stocks?

Wide-moat stocks represent companies with enduring competitive edges built through strategies like:

  • High switching costs for customers.
  • Iconic brand identities that inspire loyalty.
  • Economies of scale that keep costs low and profitability high.

These companies also boast sound balance sheets, making them desirable picks amid today’s economic uncertainties, says Susan Dziubinski, an investment specialist at Morningstar. She notes that investing in wide-moat stocks trading at a discount to their fair value has historically been a successful strategy.

The Top 10 Undervalued Wide-Moat Stocks

As of Dec 27, 2024, the 10 most undervalued wide-moat stocks, according to the Morningstar Wide Moat Focus Index, are:

  1. Estee Lauder (EL)
    • Trading 54% below fair value, making it the most undervalued on the list.
    • Its shares have fallen 47% in 2024, closing at US$73.98 on Jan 2.
  2. Huntington Ingalls Industries (HII)
  3. Pfizer (PFE)
  4. International Flavors & Fragrances (IFF)
    • The only stock with a price increase in 2024, up 2.05% year-on-year.
  5. Nike (NKE)
  6. Campbell Company (CPB)
    • Shares declined the least, falling just 6% to US$42.03.
  7. Brown-Forman (BF.B)
  8. Zimmer Biomet (ZBH)
  9. NXP Semiconductors (NXPI)
  10. MarketAxess Holdings (MKTX)
    • Trading 25% below fair value, the least undervalued stock on the list.

Why These Stocks Matter

“These wide-moat stocks represent high-quality opportunities for long-term investors, particularly those looking for discounted investments,” says Dziubinski. Companies like Estee Lauder and Pfizer bring a combination of resilience and growth potential, making them compelling picks for 2025.

Performance in 2024

The list reflects diverse performance:

  • Biggest decline: Estee Lauder’s shares tumbled 47% in 2024.
  • Steady performers: Campbell’s Co weathered the storm, dropping just 6%.
  • Notable growth: International Flavors & Fragrances bucked the trend, gaining 2.05%.

An Investment Opportunity

While markets face uncertainties, Morningstar believes these stocks are positioned to thrive in the long run. With sound fundamentals and significant discounts to fair value, they offer investors a chance to buy into companies with decades of competitive dominance at compelling prices.

For long-term value hunters, Morningstar’s wide-moat picks could be the cornerstone of a resilient portfolio in 2025.

Thank you

DBS Bid Stalls, Semiconductor & Solar Deals Shine, Banking & Property Moves Stir Malaysia Market

DBS Bid Stalls, Semiconductor & Solar Deals Shine, Banking & Property Moves Stir Malaysia Market SGX:D05.SI:DBS GroupKL:2488.KL:Alliance Bank MalaysiaDBS Group Holdings’ plan to buy into Alliance Bank Malaysia has stalled. Both DBS and Alliance’s...

Global Markets Rally in Q3 2025: US Stocks Hit Records, Asia Extends Winning Streak, Europe Outperforms – Key Insights & STI Leaders 123

Broker Name: OCBC Investment Research Date of Report: 1 October 2025 Excerpt from OCBC Investment Research report. Report Summary Global equities posted strong quarterly gains, driven by optimism around artificial intelligence, easing inflation, and...

Mynews Holdings (MNHB) Stock Analysis 2025: Growth Outlook, Financials & ESG Insights

Maybank Investment Bank Berhad Report Date: September 18, 2025 Mynews Holdings Berhad (MNHB): Poised for Robust Growth and Margin Expansion in Malaysian Convenience Retail Executive Summary Mynews Holdings Berhad (MNHB), a leading name in...